For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Impairment - intangibles, net | - | - | - | 4,720* |
| Impairment - goodwill | - | - | - | 44,483* |
| Cost of revenue | 31 | 342 | 253 | 695* |
| Research and development | 2,774 | 1,971 | 3,659 | 983* |
| Selling, general, and administrative | 2,916 | 2,404 | 3,485 | -1,802* |
| Total cost of revenue and operating expenses | 5,721 | 4,717 | 7,397 | 49,078* |
| Revenue | - | - | - | -127* |
| Loss from operations | -5,721 | -4,717 | -7,397 | -49,205* |
| Convertible notes fair value adjustment | 3,508 | -1,427 | -190 | 8,836* |
| Warrant liabilities fair value adjustment | 231 | 141 | -38 | 8,343* |
| Interest expense | 749 | 720 | 662 | -200* |
| Interest income | 79 | 102 | 164 | -78* |
| Other (expense) income, net | 12 | 102 | -46 | 1,681* |
| Total other (gain) income, net | -4,397 | 770 | -316 | -15,376* |
| Net (loss) income | -10,118 | -3,947 | -7,713 | -64,581* |
| Foreign currency translation adjustment | 4 | -39 | -61 | 28* |
| Comprehensive (loss) income | -10,114 | -3,986 | -7,774 | -64,553 |
| Basic EPS | -0.66 | -0.26 | -0.5 | -4.168 |
| Diluted EPS | -0.66 | -0.35 | -0.51 | -4.786 |
| Basic Average Shares | 15,381,565 | 15,381,565 | 15,375,521 | 15,487,748 |
| Diluted Average Shares | 15,381,565 | 15,381,565 | 15,375,521 | 13,487,748 |
Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. (ADGM)